Atazanavir Twice Daily

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2006
The purpose of this clinical research study is to assess the pharmacokinetics of atazanavir administered twice-daily relative to historical data from atazanavir/ritonavir 300/100 mg, given once daily.
Epistemonikos ID: 01ca57c00c8634122180599069d3fadaef9b2327
First added on: Dec 01, 2021